Keypoints
t-AML, sAML, AML-MRC can be nowadays clinically, morphologically and genetically (cytogenetics, somatic mut) identified
In these pts (most > 60 y of age) CPX-351 enables efficient and safe delivery of intensive chemotherapy
Consolidation with HCT in these pts is curative with real life data of OS 60%

Παρουσιαστής: Σπυριδωνίδης Αλέξανδρος
Συμμετέχοντες: Τσοκάνας Δημήτριος, Λιγκα Μαρία, Βεριγου, Βαλερα
Διάρκεια: 25 λεπτά